CoChat

Digoxin and Risk of Death in Adults With Atrial Fibrillation: The ATRIA-CVRN Study

Open access
Freeman, James V., Reynolds, Kristi, Fang, Margaret, Udaltsova, Natalia, Steimle, Anthony, Pomernacki, Niela K., Borowsky, Leila H., Harrison, Teresa N., Singer, Daniel E., Go, Alan S. · 2015 · Circulation: Arrhythmia and Electrophysiology
Cited by 80

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background—: Digoxin remains commonly used for rate control in atrial fibrillation, but limited data exist supporting this practice and some studies have shown an association with adverse outcomes. We examined the independent association between digoxin and risks of death and hospitalization in adults with incident atrial fibrillation and no heart failure. Methods and Results—: We performed a retrospective cohort study of 14 787 age, sex, and high-dimensional propensity score-matched adults with incident atrial fibrillation and no previous heart failure or digoxin use in the AnTicoagulation and Risk factors In Atrial fibrillation-Cardiovascular Research Network (ATRIA-CVRN) study within Kaiser Permanente Northern and Southern California. We examined the independent association between newly initiated digoxin and the risks of death and hospitalization using extended Cox regression. During a median 1.17 (interquartile range, 0.49–1.97) years of follow-up among matched patients with atrial fibrillation, incident digoxin use was associated with higher rates of death (8.3 versus 4.9 per 100 person-years; P <0.001) and hospitalization (60.1 versus 37.2 per 100 person-years; P <0.001). Incident digoxin use was independently associated with a 71% higher risk of death (hazard ratio, 1.71; 95% confidence interval, 1.52–1.93) and a 63% higher risk of hospitalization (hazard ratio, 1.63; 95% confidence interval, 1.56–1.71). Results were consistent in subgroups of age and sex and when using intent-to-treat or on-treatment analytic approaches. Conclusions—: In adults with atrial fibrillation, digoxin use was independently associated with higher risks of death and hospitalization. Given other available rate control options, digoxin should be used with caution in the management of atrial fibrillation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circep.114.002292

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 80

Metadata

Authors
Freeman, J. V., Reynolds, K., Fang, M., Udaltsova, N., Steimle, A., Pomernacki, N. K., Borowsky, L. H., Harrison, T. N., Singer, D. E., & Go, A. S.
Venue
Circulation: Arrhythmia and Electrophysiology
Published
2015-02
Volume
8
Issue
1
Pages
49-58
ISSN
  • 1941-3084 (ISSN-L)
  • 1941-3149
OpenAlex
W2112439830
Cited by
80
References
15
FWCI
6.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Digoxin and Risk of Death in Adults With Atrial Fibrillation: The ATRIA-CVRN Study. https://app.cochat.ai/papers/10.1161/circep.114.002292
The paper
Freeman, J. V., Reynolds, K., Fang, M., Udaltsova, N., Steimle, A., Pomernacki, N. K., Borowsky, L. H., Harrison, T. N., Singer, D. E., & Go, A. S. (2015). Digoxin and Risk of Death in Adults With Atrial Fibrillation: The ATRIA-CVRN Study. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.114.002292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.